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S U M M A R Y
Objectives: The Crimean-Congo hemorrhagic fever (CCHF) virus can spread from person to person and
may cause nosocomial outbreaks among healthcare workers (HCWs). The US Centers for Disease Control
and Prevention have recommended the use of personal protective equipment (PPE). We investigated the
compliance of HCWs with PPE usage during the follow-up of patients, and also the number of risky
contacts that occurred between patients and HCWs. We also aimed to determine the seroprevalence of
CCHF virus in HCWs.
Methods: This study was conducted at Cumhuriyet University Education and Research Hospital, a
medical center located in a highly endemic area for CCHF where a total of 1284 conﬁrmed CCHF patients
were followed-up between 2002 and 2012. All HCWs who were at risk of CCHF virus contact and
infection were included in the study. The compliance of the HCWs with PPE usage and the number of
contacts that had occurred were recorded. HCW serum samples were analyzed for CCHF virus IgM and
IgG by ELISA.
Results: The total rates of PPE usage were 93.7% for gowns, 77.4% for gloves, and 38.9% for masks; the
highest compliance was detected in the infectious diseases ward: 100%, 88.6%, and 82.9%, respectively. A
total of four HCWs had a history of high-risk contact with contaminated material (two percutaneous
exposure and two mucosal contacts), but the number of low-risk contacts was quite high. The total
seroprevalence rate was only 0.53%.
Conclusions: Although the HCWs at our medical center have dealt with an extremely high number of
CCHF patients during the last decade, the total seropositivity for CCHFV IgG was only 0.53%. This low rate
may be a result of high compliance with PPE usage and also regular education programs.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a potentially fatal
viral infection mostly reported from Africa, Asia, Eastern Europe,
and the Middle East.1,2 The CCHF virus (CCHFV) is a tick-borne
virus belonging to the genus Nairovirus of the Bunyaviridae family.
This virus generally causes an acute febrile illness in humans, often
accompanied by hemorrhagic manifestations, and has a mortality
rate of 5–30%.3 Humans are infected mostly by tick bites
(Hyalomma spp) or by direct contact with the blood or tissue of§ This study was presented as a poster at the 23rd European Congress of Clinical
Microbiology and Infectious Diseases (ECCMID), Berlin, Germany, April 27–30,
2013.
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http://dx.doi.org/10.1016/j.ijid.2013.05.005viremic livestock.4,5 However, CCHFV may also spread from person
to person and can cause nosocomial outbreaks with a high
mortality rate among healthcare workers (HCWs). The activities
with a high risk of viral transmission include needle-stick injury,
interventions for gastrointestinal bleeding, emergent operations
for unsuspected cases, and unprotected handling of infected
materials.6,7 Other routes of transmission such as close contact and
respiratory contact are the subject of debate. The US Centers for
Disease Control and Prevention have recommended that if a
patient with a viral hemorrhagic fever has respiratory symptoms, a
face shield or surgical mask and eye protection should be used by
HCWs to prevent droplet contact. However, epidemiological
studies indicate that such infections are not readily transmitted
from person to person by airborne route.5,8–11
CCHF cases were ﬁrst identiﬁed in Turkey in 2002, and,
according to the literature, this country is now one of the most
risky areas for the disease.1,12–15 However, the mortality rate ofses. Published by Elsevier Ltd. All rights reserved.
Table 1
Demographic characteristics of healthcare workers at risk of Crimean-Congo
hemorrhagic fever virus infection
Characteristics
Age, years, median (min–max) 31 (20–55)
Gender, n (%)
Female 104 (54.7)
Male 86 (45.3)
Occupation, n (%)
Nurse 57 (30.0)
Physician 47 (24.7)
Housekeeping staff 41 (21.6)
Laboratory technician 45 (23.7)
Department, n (%)
Infectious diseases 35 (18.4)
Pediatric infectious diseases 20 (10.5)
Emergency department 26 (13.7)
Internal medicine 21 (11.1)
Hematology 14 (7.4)
ICU 23 (12.1)
Laboratory 51 (26.8)
Years of work, median (min–max) 5 (1–21)
History of tick exposure, n (%) 4 (2.1)
Living in an endemic region, n (%) 7 (3.7)
History of travel to an endemic region, n (%) 93 (48.9)
History of risky activity, n (%)
Animal husbandry 4 (2.1)
Farming 3 (1.6)
Hunting 5 (2.6)
Butchery 1 (0.5)
Total, N (%) 190 (100)
ICU, intensive care unit.
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known from molecular epidemiology and phylogenetic studies
that there are different genetic strains and this may explain the
differences in mortality rates in different regions of the
world.7,12,16–18 The majority of cases in Turkey have been reported
from the northeastern provinces (Tokat, Sivas, Gumushane,
Amasya, Yozgat, and Corum), and our hospital is located in this
highly endemic region, serving as a tertiary care reference hospital.
A total of 1284 conﬁrmed CCHF cases have been followed-up at our
hospital since 2002.
We conducted this study to determine the compliance with
personal protective equipment (PPE) usage of HCWs during the
follow-up of patients with CCHF; HCWs worked on the wards or
handled contaminated materials from these patients in the
laboratory. Furthermore, we recorded the number of risky contacts
between the patients and HCWs, and also analyzed the serum
seropositivity for CCHFV IgM and IgG of all HCWs at risk, and thus
aimed to determine the possible risk factors for seropositivity
among HCWs in Turkey.
2. Materials and methods
This study was conducted at Cumhuriyet University Education
and Research Hospital. This hospital is located in a high-risk region
for CCHF where the disease is endemic, and serves as a tertiary care
reference hospital for the northeastern part of the country. Acute
and convalescent phase serum samples of the patients were sent to
the virology laboratory of Reﬁk Saydam Hygiene Center in Ankara
for serologic and virologic analysis. The serum samples of the
patients with epidemiological risk factors or with clinical and
laboratory ﬁndings compatible with CCHF were analyzed for
CCHFV RNA by reverse-transcriptase PCR and CCHFV-speciﬁc IgM
by ELISA; if at least one revealed a positive result, the patient was
deﬁned as a conﬁrmed CCHF case. A total of 1284 conﬁrmed CCHF
patients were followed up at our hospital between 2002 and 2012;
91 of these patients (7.09%) died.
Our aim was to analyze all the HCWs at risk of viral infection.
Therefore the study group included all the HCWs (physicians,
nurses, housekeeping staff, and laboratory technicians) who have
worked on the wards, and also HCWs in the laboratory who may
have handled contaminated material. The following departments
were included: infectious diseases, pediatric infectious diseases,
emergency department, internal medicine, hematology, intensive
care unit (ICU), and the laboratories. A face to face interview
questionnaire was used for data collection and was completed
with the HCWs 3 months after the care of the last deﬁnitive case
(December 2012). An interviewer explained the study purposes to
all the HCWs and obtained their consent. All the HCWs who had
been at risk accepted participation in the study. The questionnaire
was used to collect information on HCW characteristics, including
age, sex, occupation, working department, time HCW had worked
in the selected department, history of tick exposure, history of
travel to an endemic region, living in an endemic region, and
history of any risky activity (animal husbandry, farming, hunting,
and butchery), and also on compliance of the HCWs with the
recommended precaution procedures. Recommendations for
infection control while providing care to patients with suspected
or conﬁrmed CCHF include the following: isolation of the patient
and standard infection control precautions, i.e., basic hand
hygiene, use of PPE (gloves, gown, and mask), and also the use
of face shields and eye protection when caring for patients with
respiratory symptoms to prevent droplet contact. Samples taken
from CCHF patients should have been handled by trained and
equipped laboratory staff.5,7,19,20 In addition, HCWs were ques-
tioned in detail regarding their exposure to the blood or
sanguineous body ﬂuids (saliva, sweat, vomit, feces, and urine)of CCHF patients and also other possible low-risk contacts that
could result in the possibility of viral transmission. The contacts
that occurred between the patients and the HCWs were recorded
in detail and were grouped into the following: percutaneous
exposure, mucosal contact with blood or sanguineous body ﬂuids,
skin (intact) contact with blood or other sanguineous body ﬂuids,
physical contact with a CCHF patient without wearing gloves, and
proximity to a CCHF patient closer than one meter (without mask).
Three months after the last deﬁnitive case (December 2012), serum
samples were obtained from the HCWs and were analyzed for
CCHFV IgM and IgG by ELISA (Vectocrimean-CHF-IgM and IgG,
Vector-best, Koltsovo, Novosibirsk, Russia), in accordance with the
manufacturer’s recommendations; this was carried out in the
Department of Medical Microbiology, Cumhuriyet University
School of Medicine.
2.1. Statistical analysis
SPSS version 14 for Windows (SPSS Inc., Chicago, IL, USA) was
used for the statistical analysis. Parametric data were expressed as
the median (min–max) and categorical data as percentages.
Proportions for categorical variables were compared using the
Chi-square test. A p-value of <0.05 was considered signiﬁcant in all
analyses.
3. Results
A total of 190 HCWs, including 57 (30.0%) nurses, 47 (24.7%)
physicians, 45 (23.7%) laboratory technicians, and 41 (21.6%)
housekeeping staff participated in the study. Their median age was
31 years (range 20–55 years) and 104 (54.7%) were women. The
basic characteristics of the study participants are shown in Table 1.
Compliance of the HCWs with PPE usage during the follow-up
period was also analyzed. There were no statistically signiﬁcant
differences between the male and female participants (p > 0.05).
The use of gloves in the older age group (31 years) was lower
(p = 0.003), but there were no statistically signiﬁcant differences
Table 3
Possible risk factors for viral transmission from patients to healthcare workers (N =
190)
Possible risk factors for transmission n (%)
Percutaneous exposure 2 (1.1)
Mucosal contact with blood or sanguineous body ﬂuids 2 (1.1)
Skin (intact) contact with blood 20 (10.5)
Skin (intact) contact with sanguineous body ﬂuids 12 (6.3)
Physical contact with a CCHF patient without wearing gloves 25 (13.2)
Closeness to a CCHF patient nearer than one meter (without mask) 45 (23.7)
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groups (p > 0.05, Table 2). While there were no differences
between the occupational groups with regard to gown use (p =
0.13), the use of gloves and masks were lower among laboratory
technicians (p = 0.001, p = 0.001, respectively). Total rates of PPE
usage among the HCWs were found to be 93.7% for gowns, 77.4%
for gloves, and 38.9% for masks; the highest compliance was found
among the HCWs of the infectious diseases ward: 100%, 88.6%, and
82.9%, respectively. However, PPE usage in the hematology
department was signiﬁcantly lower than in the other departments
(p < 0.05, Table 2).
A history of needle-stick injury contaminated with blood was
reported by two HCWs, and a history of mucosal contact with
blood or sanguineous body ﬂuids was reported by two others.
Ribavirin prophylaxis was provided to all but the two HCWs with
mucosal contact, who refused this therapy. None of the four HCWs
developed any signs or symptoms of the disease (fever, headache,
vomiting, bleeding), or had any laboratory ﬁndings (alanine/
aspartate transaminase elevation, leukopenia, thrombocytopenia)
compatible with CCHF disease. The low-risk contacts were also
recorded and are shown in Table 3. None of the HCWs were
positive for CCHF IgM and only a nurse working on the internal
medicine ward was positive for CCHF IgG (very high level of
positivity was observed according to cut-off values). She reported
no history of tick bites and no history of febrile disease, but had a
history of travel to an endemic region. Therefore, this may not be
false-positivity; she might have experienced a subclinical infection
as reported previously in Turkey.17 The total seroprevalence rate
was found to be only 0.53%.
4. Discussion
Nosocomial transmission of CCHFV to HCWs has been reported
from different countries. In particular, percutaneous exposure,
interventions for gastrointestinal hemorrhage, emergency surgical
interventions, mouth to mouth resuscitation, and unsafe handling
of infected materials or patients have been reported as high-risk
activities for viral transmission.6,11,21–24 These studies suggest that
CCHF patients should be isolated and that HCWs should use PPE,
including gowns, gloves, surgical masks or face shields, and eye
protection, while giving care to the patients or handling their blood
and other sanguineous body ﬂuids. In most of the nosocomialTable 2
Compliance with personal protective equipment usage of 190 healthcare workers
Rate of adherences to protective equipme
Gown p-Value 
Gender 0.34 
Female 99 (95.2) 
Male 79 (91.9) 
Age, years 0.88 
20–30 85 (93.4) 
31 93 (93.9) 
Job 0.13 
Nurse 52 (91.2) 
Physician 47 (100) 
Laboratory technician 40 (88.9) 
Housekeeping staff 39 (95.1) 
Department 0.001 
Infectious diseases 35 (100) 
Pediatric infectious diseases 20 (100) 
Emergency department 26 (100) 
Internal medicine 20 (95.2) 
Hematology 8 (57.1) 
ICU 23 (100) 
Laboratory 46 (90.2) 
Total 178 (93.7) 
ICU, intensive care unit.outbreaks, unsuspected cases who were admitted with massive
bleeding were the origin of infection in the healthcare setting.9,25,26
In endemic areas, each patient with a febrile hemorrhagic
syndrome should be considered to have a viral hemorrhagic fever
until the deﬁnitive diagnosis.9 The availability of appropriate
protective equipment and education of HCWs about safe clinical
practices and infection control is the mainstay of the prevention of
nosocomial spread.27 Almost all of the CCHF patients were
admitted to our hospital through the emergency unit, where the
ﬁrst evaluation of these patients was performed. Therefore, the
standard isolation procedures should be applied in the emergency
department before transfer of the patient to the infectious diseases
department. Patients with CCHF were infrequently hospitalized in
other clinics, such as hematology, internal medicine, and ICU, with
a diagnosis of severe sepsis or for other hematologic diseases. A
total of four patients (4/190; 2.1%) were initially hospitalized on
other wards and then transferred to the infectious diseases ward.
From the ﬁrst years of the CCHF epidemic in Turkey, all HCWs in
our hospital at risk of nosocomial transmission have been educated
regarding transmission routes and standard precaution methods.
This education has been repeated each year just before the
outbreak season.
Gaps in infection control practices are the common factors in
the occurrence of nosocomial outbreaks.27 A study conducted in
Iran reported a 3.87% seroprevalence rate among HCWs with a
history of exposure to patients with CCHF directly or with their
blood or sanguineous ﬂuids, and no seropositivity among HCWs
with any history of exposure.8 In another trial, the compliance with
gloves and mask use was 44% among HCWs who were in close
contact with patients with CCHF.2 The compliance rates among ournts usage, n (%)
Gloves p-Value Mask p-Value
0.61 0.76
79 (76.0) 47 (45.2)
68 (79.1) 28 (32.6)
0.003 0.78
79 (86.8) 35 (38.5)
68 (68.7) 40 (40.4)
0.001 0.001
41 (71.9) 27 (47.4)
43 (91.5) 24 (51.1)
27 (60.0) 5 (11.4)
36 (87.8) 18 (43.9)
0.005 0.001
31 (88.6) 29 (82.9)
14 (70.0) 10 (50.0)
22 (84.6) 9 (34.6)
18 (85.7) 6 (28.6)
8 (57.1) 3 (21.4)
22 (95.7) 9 (39.1)
32 (62.7) 16 (31.4)
147 (77.4) 74 (38.9)
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the highest rate on the infectious diseases ward and the lowest rate
on the hematology ward. Although these patients stay for a short
time in the emergency department and are immediately trans-
ferred to the infectious disease clinic, some applications, i.e.,
intravenous catheterization, urinary catheterization and monitor-
ing, may be applied to these patients before hospitalization;
however most of the interventions and all treatments, i.e.,
replacement of intravenous ﬂuids, blood, and blood products
transfusion, take place on the infectious diseases ward. Therefore,
it is not surprising that the highest compliance rate to PPE usage
among HCWs was recorded in this clinic.
The substantial impact of education on adherence to the use of
recommended barrier precautions has been reported.28 Occupa-
tional groups were compared for compliance with PPE usage, and
laboratory technicians had the lowest compliance rates for the use of
gloves and masks. The compliance rates to all three PPE (gowns,
gloves, and masks) were higher among physicians, which may be
associated with better education and awareness. They had been
trained on methods of infection control at medical school to a greater
extent than the other HCWs. Training programs on infection control
issues are required to improve the awareness of all HCWs, and this
training should include all students in any health-related programs.
Nosocomial outbreaks have been reported in several studies,
with higher mortality rates. Percutaneous exposure to contaminated
material is believed to have the highest risk for viral transmission
from person to person.8,9 A needle-stick injury occurred in two
HCWs in our study. Both injuries occurred during peripheral venous
blood sampling for routine control tests. At the time of injury, both
patients were in the convalescence period of CCHF disease and both
HCWs were using gloves. Although the efﬁcacy of ribavirin for the
prophylaxis and therapy of CCHF is still unclear, ribavirin
prophylaxis was offered.12,13 They were observed for the develop-
ment of clinical signs and laboratory ﬁndings of CCHF disease, and
neither HCW developed any signs or symptoms. Even though a high
rate of transmission with percutaneous exposure has been reported
in the literature, two HCWs did not develop the disease and CCHFV
IgM and IgG tests were negative. Because both of the patients
involved were in the convalescence period, both HCWs were
wearing gloves, and both HCWs took ribavirin prophylaxis, clinical
disease or seropositivity did not occur.
There is concern regarding transmission via respiratory contact.
Epidemiologic studies indicate that viral hemorrhagic fever
infections are not readily transmitted by airborne route.9,24 A
history of mucosal contact with blood or sanguineous body ﬂuids
was reported by two of our participants. A physician and a nurse
reported probable mucosal contact with the oropharyngeal
secretions of a patient with mucosal bleeding while applying
cardiopulmonary resuscitation. Both HCWs were wearing gowns
and gloves, but neither used a mask during the procedure. This
patient was initially hospitalized with a suspicion of a hematologic
disorder on the internal medicine ward, and the probable mucosal
contact occurred on this ward before the patient was diagnosed
with CCHF. Although ribavirin prophylaxis was recommended,
both HCWs refused to take the pills. They also did not develop
CCHF disease and were seronegative for CCHFV IgM and IgG. In
addition, 45 HCWs (23.7%) related getting close (nearer than one
meter) to CCHF patients, without wearing masks, but CCHFV IgM
and IgG serologies were negative in all of them. While the usage
rates of gowns and gloves were very high, the usage rate of masks
was low. However, the seroprevalence rate was very low and this
may be explained by high compliance of HCWs to PPE usage except
masks. Furthermore, this may support the idea that CCHFV is not
readily transmitted from person to person by airborne route. A
similar study from Turkey reported the lack of airborne transmis-
sion of CCHFV to HCWs.5 However, if a patient with a viralhemorrhagic fever has respiratory symptoms, or aerosol-generat-
ing procedures are used, additional precautions (N95 or FFP2
respirator) are indicated to prevent possible exposure to airborne
particles that may contain the virus.29,30
The spread of CCHFV from person to person through close
contact and direct contact with blood and other sanguineous body
ﬂuids of patients has also been reported.8,9,14 Direct contact with
blood, clothes, and sheets were reported as the probable
transmission route in three cases in a nosocomial outbreak, and
direct cutaneous contact with contaminated blood was reported in
a case in another study.9,11 In a seroprevalence study, more
frequent seropositivity was demonstrated among HCWs who
reported intact skin contact with body ﬂuids.8 A total of 32 HCWs
reported an intact skin contact with blood or body ﬂuids and 25
HCWs reported physical contact with CCHF patients without
wearing gloves; none of them developed clinical infections or
seropositivity.
The phylogenetic and molecular epidemiology analysis of
CCHFV has demonstrated the existence of different genetic strains
and higher mortality rates in Asian strains.7,12,16 The mean
mortality rate in our country was about 5% and this rate is lower
than those of other countries.7,12 A study from Iran reported a
3.87% seroprevalence rate among HCWs who had a history of
exposure to patients with CCHF, their blood, or sanguineous
ﬂuids.8 We observed a lower seropositivity rate among HCWs in
the presented study. CCHF strains in Turkey are signiﬁcantly
similar to strains in Russia and Kosovo, and the lower mortality
rate might be due to the differences in genetic lineage.7,17,18 In
addition, these strains may be less transmissible, explaining the
lower seropositivity among HCWs working at risk in Turkey.
In conclusion, we found the compliance of HCWs with the usage
of PPE to be high. Although our center is one of the hospitals with
the highest number of CCHF patients during the last decade, the
seroprevalence rate among HCWs at risk was very low. This may be
due to the higher compliance rates and also due to regular
education. However, further studies are needed to evaluate
whether the recommended PPE usage is sufﬁcient to prevent
nosocomial transmission among HCWs working in countries with
more dangerous strains.
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